Traditional Medicine System Set for Revival in India
… regulate and increase the quality of traditional Indian medicine so they can be sold on an estimated $100 billion global alternative medicine market.
Go to Source
Good Health is Your Greatest Wealth……Virgil
… regulate and increase the quality of traditional Indian medicine so they can be sold on an estimated $100 billion global alternative medicine market.
Go to Source
The decision, which doesn't rule on whether traditional or alternative medicine works but on the mother's right to choose an aboriginal option, begs the …
Go to Source
The grant is funded by the National Center for Complementary & Alternative Medicine, part of the National Institutes of Health (1R01AT007083-01A1).
Go to Source
Austrian social security law is rather restrictive when it comes to refunding the costs of alternative medical treatments. Although the plaintiff was …
Go to Source
MUMBAI (Reuters) – Ranbaxy Laboratories Ltd has sued the U.S. Food and Drug Administration (FDA) for revoking approvals granted to the Indian firm to launch copies of two drugs including AstraZeneca Plc’s heartburn pill Nexium, court documents showed. The FDA told Ranbaxy this month that it believed its decisions to grant the company tentative approvals for copies of Nexium and Roche AG’s antiviral Valcyte were “in error”, after it found that Ranbaxy’s plants at the time were not compliant with the FDA’s manufacturing quality standards. …
Go to Source
The purpose of exercise Max Thunder is to enhance combat readiness of the U.S. and ROK air forces and supporting forces through combined and …
Go to Source
By Eric M. Johnson SEATTLE (Reuters) – The family of Reggae icon Bob Marley and a Seattle-based private equity firm on Tuesday said they are launching the first global cannabis brand with marijuana products sold under a name long tied to a plant he lovingly called "the herb". The brand, dubbed Marley Natural, marks the first time the family's name would adorn packages of cannabis products ranging from strains similar to those Bob might have smoked in his homeland Jamaica to concentrates, oils and infused lotions sold in countries and U.S. …
(Reuters) – CytRx Corp said the U.S. Food and Drug Administration placed a hold on enrolling new patients in clinical trials of its experimental cancer drug after a patient died, sending the company’s shares down 11 percent in premarket trading. The patient received the drug, aldoxorubicin, under the company’s expanded access program that makes promising drugs and devices available to patients with serious diseases who do not qualify for the trials. Patients already enrolled in the trials, currently in mid stage, will continue receiving the treatment, CytRx said. …
Go to Source
By Ben Hirschler and Simon Jessop LONDON (Reuters) – AstraZeneca touted an "industry-leading" line-up of hot new cancer drugs at an investor day on Tuesday, aiming to show it has a strong independent future after seeing off a $118 billion bid from Pfizer in May. The company also brought forward the filing date for a new lung cancer pill, and said it could win between eight and 10 new approvals in 2015-2016 for drugs dealing with a wide range of diseases. …
The book “Optimal Health with Multiple Sclerosis: A Guide to Integrating Lifestyle, Alternative, and Conventional Medicine,” which was published this …
Go to Source
India and China began their joint “Hand-in-Hand” army exercise with focus on counter-insurgency and counter-terrorism tactics, weeks after a stand-off …
Go to Source